Evaluation of Bleb Morphology and Reduction in IOP and Glaucoma Medication following Implantation of a Novel Gel Stent

Table 1

Patient demographics and baseline characteristics.

Patients	11
Eyes	12
Gender (M/F)	5/6
Age (years)	71.3 ± 10.0
CCT (μm)	548.7 ± 44.9
Snellen BCVA	6.38 ± 3.23/10
MD (dB)	−12.5 ± 8.69 dB
Preoperative IOP (mmHg)	21.79 ± 2.8 mmHg
Number of antiglaucoma medications at baseline	2.92 ± 1.16

BCVA: best corrected visual acuity; CCT: central corneal thickness; MD: mean deviation of visual field test.